Inhibitors of Tyrosine Kinase-Dependent Signaling as Anti-Cancer Agents
$1,133,603ZIAFY2020CANIH
Division Of Basic Sciences - Nci
Investigators
Linked publications, trials & patents
Paper 38984667Paper 37181631Paper 36913882Paper 36223450Paper 36051621Paper 34163656Paper 32329959Paper 31014020Paper 30289412Paper 30174151Paper 29062027Paper 28330604Paper 28285924Paper 28185436Paper 27992122Paper 27624074Paper 27445334Paper 26152807Paper 25739367Paper 25344228Paper 25283071Paper 24987091Paper 24827688Paper 24120332Paper 23907438Paper 23241354Paper 23159568Paper 23149229Paper 23075516Paper 22988967Paper 22761439Paper 22743087Paper 22570300Paper 22422315Paper 22292814Paper 22136325Paper 22107736Paper 21950469Paper 21927934Paper 21830199Paper 21826118Paper 21765407Paper 21697602Paper 21671403Paper 21643473Paper 21443195Paper 20472436Paper 20350805Paper 19597481Paper 19362470Paper 19275759Paper 19226165Paper 19199650Paper 19122755Paper 18989951Paper 18922692Paper 18830565Paper 18719095Paper 18620523Paper 17616655Paper 17371004Paper 16317285Paper 16165154Paper 16044542Paper 16039123Paper 16020668Paper 15943469Paper 15893931Paper 15755645Paper 15719347Paper 15713392Paper 15689160Paper 15486196Paper 15056012Paper 15047187Paper 14761181Paper 14609321Paper 14521921Paper 12941322Paper 12852970Paper 12809529Paper 12801226Paper 12678845Paper 12519063Paper 10987981Paper 10853661Paper 10715157Patent 8916159Patent 8754081Patent 8569360Patent 7871981Patent 7825216Patent 7767645Patent 7425537Patent 7226991Patent 7132392Patent 6977241Patent 6307090
View original record on NIH RePORTER →